Skip to content

DR. LING YEE CHOW

Active
Private limited companyfounded 2019active for 7 yearsWuytjesstraat 3, 2220 Heist-op-den-Berg, BelgiumKBO/BCE: BE 0723.572.587
Summary

DR. LING YEE CHOW has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €76,409 and a net result of €55,949. Equity has been growing by about 20% per year since 2019. Its solvency ranks better than 27% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 25-03-2019 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.287.129.049 2861 Sint-Katelijne-Waver, since 25-03-2019
Financial year end
31 December
Peppol
Reachable since 09-01-2026

Board and ownership

Board
  • Chow Ling YeeDirector

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€104,692
▲ 19.9%
Turnover
≈ €190,000
estimated
Profit
€55,949
▲ 37.0%
Equity
€76,409
▲ 2.2%
Total assets
€233,679
▼ 9.1%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.87, cash €114,319Size: total assets €233,679Figures for financial year 2025 (filed on 05-06-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 51% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 58+4
equity 32.7% of total assets
Liquidity 91+24
short-term debt 23.7% · cash 48.9%
Profitability 99+10
return on assets 23.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.87 (1.94 in 2024), above the usual 1.5. Short-term debt is 23.7% and cash 48.9% of total assets. However, 67.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 28% of them on solvency, 77% on liquidity, 59% on profitability and 42% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.87, cash €114,319
NBB · annual accounts
lowers risk · Size: total assets €233,679
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 05-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
56 days early
2024
57 days early
2023
37 days early
2022
56 days early
2021
44 days early
2020
58 days early
2019
45 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 50 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 7 years View

Recent changes

  1. · Gazette deed Legal-form change · Resignations & appointments
  2. · Gazette deed Incorporation
All 12 events

Comparable companies

These companies have the same main activity as DR. LING YEE CHOW: general medical practice (NACE 86210). They are comparable in size and age: total assets between €203,000 and €273,000, founded between 2018 and 2020.

CompanyTotal assetsGross margin
DR. LING YEE CHOW Heist-op-den-Berg€233,679€104,692
Huisarts Martine Schrage Turnhout€247,732€99,953
Dr. Barbara Gilis Kontich€225,491€109,138
DR. CAROLIEN DE MAEYER Turnhout€272,728€105,021
Dr. Provinciael Pieter Lint€208,294€97,940
Dr. Lynn Hopchet Edegem€203,296€110,871
DR. WOUTER BILLIET Tielt€242,529€105,337
Full comparison

Key facts about DR. LING YEE CHOW

What is the company number of DR. LING YEE CHOW?
The company number of DR. LING YEE CHOW is 0723.572.587. The VAT number is the same number with BE in front: BE 0723.572.587.
Where is DR. LING YEE CHOW based?
The registered office is at Wuytjesstraat 3, 2220 Heist-op-den-Berg.Company details
What does DR. LING YEE CHOW do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. LING YEE CHOW?
The legal form of DR. LING YEE CHOW is Private limited company (BV).
When was DR. LING YEE CHOW founded?
DR. LING YEE CHOW was founded on 25-03-2019.
Is DR. LING YEE CHOW still active?
Yes, DR. LING YEE CHOW is an active enterprise in the KBO register.
What is the turnover of DR. LING YEE CHOW?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €104,692 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €240,000.Financials
Is DR. LING YEE CHOW profitable?
In financial year 2025, DR. LING YEE CHOW made a profit of €55,949.
Where can I find the annual accounts of DR. LING YEE CHOW?
DR. LING YEE CHOW filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. LING YEE CHOW due?
DR. LING YEE CHOW must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.